Erythrocyte Na+-Li+ countertransport and blood viscosity in arterial hypertension. 1986

F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami

The aim of this study was to evaluate together the main hemorheologic parameters and one of the transmembrane ion transport systems in erythrocytes of subjects with normal and elevated blood pressure. Three sex-, age-, and weight-matched groups consisting of 15 normotensive subjects (NT) with no parental hypertension, 15 patients with essential hypertension (EH) at stage 1-II WHO, and eight patients with secondary hypertension (Sec.H), respectively, were studied. Red blood cell Na+-Li+ countertransport (CTT), blood viscosity (eta B) at shear rates of 230 X S-1, 115 X S-1, and 46 S-1 and plasma viscosity (eta P) at shear rate of 46 X S-1 were measured. Plasma proteins and fibrinogen were also evaluated. CTT was higher in EH than in NT (P less than 0.01), while no significant difference was found between NT and Sec. H patients. eta B at 115 X S-1 and 46 X S-1 was higher in EH, but not in Sec. H, than in NT patients (P less than 0.05). No difference in eta P, plasma proteins and fibrinogen levels was observed between EH and NT. Elevated eta B and/or CTT may indicate a structural alteration in the erythrocyte membrane of some essential hypertensive patients. This is consistent with the hypothesis that a widespread membrane disorder is involved in the pathogenesis of primary hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill

Related Publications

F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
December 1990, Acta paediatrica Scandinavica,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
August 1991, Kardiologiia,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
September 1999, Clinical science (London, England : 1979),
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
January 1984, Clinical and experimental hypertension. Part A, Theory and practice,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
November 1988, Journal of hypertension,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
August 1996, Journal of hypertension,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
October 1991, Journal of the Formosan Medical Association = Taiwan yi zhi,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
August 1988, Kardiologiia,
F Fallo, and M Procidano, and V de Angelis, and F Manoni, and F Mantero, and A Girolami
January 1993, Biology of the neonate,
Copied contents to your clipboard!